 |
|
|
CRC Investigators in the News
|
UAMS-Developed Skin Cream Now in
Stores |
 |
|
JAN. 17, 2006, A skin cream developed by a University of Arkansas
for Medical Sciences (UAMS) researcher is now being marketed by Balm
Innovations LLC, a UAMS BioVentures startup company.
Called Dr. Teatrie's Omnibalm™, the cream is an innovation by Bill
Gurley, Ph.D., director of the UAMS Clinical Pharmacokinetics
Research Laboratory and professor of pharmaceutical sciences in the
UAMS College of Pharmacy. (Read
More)
|
|
How Obesity Relates to Diabetes |
|
 |
|
August 18, 2005,
Researchers at the University of Arkansas for Medical Sciences (UAMS)
are examining how obesity relates to diabetes development in a study
funded by three collaborative grants totaling $2.2 million from the
National Institutes of Health.
(Read
More) |
|
| |
|
|
UAMS College of Nursing Dedicates Interventions Research Center
|
 |
| MAY
23, 2005, the University of Arkansas for Medical Sciences (UAMS)
College of Nursing put scissors to ribbon recently to dedicate the
opening of its Tailored Biobehavioral Interventions Research Center
(T-BIRC), launching a new perspective in patient care.
(Read
More) |
|
CRC's Ashley Swain
named Most Valuable Player for month of July. The Clinical
Programs Recognition Council has named Ashley Swain the Most Valuable
Player for the month of July!
(Read
More) |
|
 |
| |
|
FDA Officially Bans the Sale of All Ephedra Products
"It's About Time", Says UAMS Ephedra Expert |
|
On April 12, 2004, the Food and Drug Administration (FDA)
officially banned the sale of all dietary supplements containing ephedra - a
naturally occurring substance found in plants that has powerful stimulant
effects on the nervous system and heart. Bill Gurley, Ph.D., a professor of
pharmaceutical sciences in the College of Pharmacy at the University of Arkansas for Medical Sciences, has been
investigating the possible health risks from taking ephedra-based
supplements for eight years, and knows just how badly this ban was needed.
(April 16, 2004) (Read More) |
|
 |
| |
| Associate CRC Program Director Receives NIH Merit Award |
|
A biochemist at the
University of Arkansas for Medical Sciences (UAMS) is leading the study of
how biotin, a micronutrient found in liver, egg yolk, milk, and yeast, may
affect fetal development. There appears to be a link between the pregnant
woman's biotin intake and cleft palates, in which the roof of the baby's
mouth is split. There also may be a link to severely shortened arms and
legs. (Jan 3, 2003) (Read
More) |
|
 |
|
|
|
CRC Investigator Researching Risk of Brain
Injury in Very Low Birth Weight (VLBW) Infants |
|
Jeffrey R. Kaiser, M.D., M.A.,
and a group of scientists at the University of Arkansas for Medical Sciences
(UAMS) are studying how to determine whether very low-birthweight infants
are in danger of brain injuries in the first days of life. Their
project should help physicians, nurses, and others who care for premature
and very low-birthweight babies, those born at less than 3.5 pounds, do more
to reduce the infants' risk of brain injuries. (Sept 12, 2002) (Read
More) |
|
 |
CRC Investigator Receives Pfizer Scholars Award
CRC Investigator Featured in UAMS Online, New Treatment Patent Pending
|
